PowerTOST sample size FDA full replicate T/R ratio at 85% [🇷 for BE/BA]

posted by Shuanghe  – Spain, 2016-01-26 13:55 (3377 d 05:11 ago) – Posting: # 15854
Views: 17,867

Many thanks Detlew!

❝ "Not widened yet" is the false. ...


❝ So far so good. This doesn't imply that at CV=30% the sample size is highest since we have the point estimate constraint in effect. This leads to the shift of the maximum sample size downwards of 30%.


Understood until here.

❝ This is also the case for your calculations with theta0=0.9, but not so pronounced seen as with theta0=0.85. Check it by power calculations with n=120 for theta0=0.85 or theta0=0.9 and n=32. You will find the minimum (implying max. sample size) below CV=30% in both cases.


Confused by this part. :confused:

❝ The why is not so easy to answer. ... My suggestion: Take the observed effect as is :cool:.


I think I'll just take what it is as you said. Much easier this way :-D

❝ Of course not! Even the suspicion is an injury :-D!

❝ It must be correct because PowerTOST says so :cool:.


:ok: :clap:

All the best,
Shuanghe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
17 visitors (0 registered, 17 guests [including 2 identified bots]).
Forum time: 20:07 CEST (Europe/Vienna)

It is a well-known experience that the only truly enjoyable and
profitable way of studying mathematics is the method of
“filling in details” by one’s own efforts.    Cornelius Lanczos

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5